CW

CURTISS WRIGHT CORP
7 filings tracked
industrialsaerospace defenseMID ($2B-10B)

Company Intelligence Hub

Filing history, signal momentum, and bull/bear evolution

Chronological Filing Evolution (Click to filter / toggle)

Thesis (Bull Case Evolution)

Curtiss-Wright has delivered a commanding first quarter in 2026, characterized by a potent combination of top-line acceleration and bottom-line efficiency. The company reported a 13% increase in net sales to $914 million, while operating income surged by 23% to $160 million.…

Bullish Outlook

Antithesis (Bear Case / Structural Risks)

Despite the headline growth, a closer examination of the Q1 2026 filing reveals systemic stresses in the company's cash cycle. Curtiss-Wright continues to struggle with converting earnings into cash, reporting a net cash outflow from operating activities of $5.7 million.…

Risk Factors

Read the full bull/bear analysis

You are reading the free preview. Start a free trial to unlock the complete bull & bear analysis for every CW filing.

Start Free Trial

Synthesis (Verdict & Resolution)

The Q1 2026 filing paints a picture of a company in a high-growth phase, successfully capturing the tailwinds of increased defense spending and nuclear energy demand. The operational metrics are undeniably strong, with double-digit growth in sales and a significant jump in earnings per share. The expansion of the backlog to $4.3 billion provides a critical safety net and a predictable revenue stream for the next three years. However, the disconnect between accounting earnings and cash flow remains the central point of tension for investors. The rise in working capital needs and the continued negative operating cash flow suggest that the cost of supporting this growth is substantial. The company is essentially borrowing from its balance sheet and utilizing credit facilities to fund the gap between production and collection. Ultimately, the investment thesis hinges on whether the current operational momentum can outpace the inherent risks of high debt and long-cycle government contracts. If Curtiss-Wright can stabilize its cash conversion cycle while maintaining its margin expansion, it remains a powerful compounder. Conversely, any disruption in the U.S. Navy's shipbuilding pipeline or a failure in the commercial nuclear prototype stage could rapidly erode the current valuation premium.

Selected Quarter

Core Takeaway

CW is successfully scaling its defense and nuclear business, but the growth is currently cash-intensive, leading to a divergence between reported earnings and actual cash flow.

Investor Lens

The trade-off is between impressive top-line growth and a deteriorating cash conversion cycle.

Watch Next

Quarterly operating cash flow and progress on the commercial nuclear prototype transition.

Signal Momentum Chart

Quarterly net bull/bear signal ratio. Click nodes to select a quarter.

BULLISH (+1.0)NEUTRAL (0.0)BEARISH (-1.0)+0.48Q2 '26 (10-Q)

Signal Timeline

Active Filters:Quarter: Q2 '26 (10-Q)
bullishMay 7

Net earnings increased 26% year-over-year to $128.2 million.

earnings beat
80%
bullishMay 7

Operating margin increased 150 basis points to 17.5% due to favorable absorption.

margin expansion
70%
bullishMay 7

Repurchased approximately 22,000 shares for $14 million during the quarter.

buyback
40%
neutralMay 7

Ongoing share-based compensation and restricted stock issuance.

dilution risk
30%
bullishMay 7

Net earnings increased 26% year-over-year to $128.2 million.

earnings beat
80%
bullishMay 7

Operating margin increased 150 basis points to 17.5% due to favorable absorption.

margin expansion
70%
bullishMay 7

Repurchased approximately 22,000 shares for $14 million during the quarter.

buyback
40%
neutralMay 7

Ongoing share-based compensation and restricted stock issuance.

dilution risk
30%
bullishMay 7

Net earnings increased 26% year-over-year to $128.2 million.

earnings beat
80%
bullishMay 7

Operating margin increased 150 basis points to 17.5% due to favorable absorption.

margin expansion
70%
bullishMay 7

Repurchased approximately 22,000 shares for $14 million during the quarter.

buyback
40%
neutralMay 7

Ongoing share-based compensation and restricted stock issuance.

dilution risk
30%
bullishMay 7

Net earnings increased 26% year-over-year to $128.2 million.

earnings beat
80%
bullishMay 7

Operating margin increased 150 basis points to 17.5% due to favorable absorption.

margin expansion
70%
bullishMay 7

Repurchased approximately 22,000 shares for $14 million during the quarter.

buyback
40%
neutralMay 7

Ongoing share-based compensation and restricted stock issuance.

dilution risk
30%
bullishMay 7

Net earnings increased 26% year-over-year to $128.2 million.

earnings beat
80%
bullishMay 7

Operating margin increased 150 basis points to 17.5% due to favorable absorption.

margin expansion
70%
bullishMay 7

Repurchased approximately 22,000 shares for $14 million during the quarter.

buyback
40%
neutralMay 7

Ongoing share-based compensation and restricted stock issuance.

dilution risk
30%
bullishMay 7

Net earnings increased 26% year-over-year to $128.2 million.

earnings beat
80%
bullishMay 7

Operating margin increased 150 basis points to 17.5% due to favorable absorption.

margin expansion
70%
bullishMay 7

Repurchased approximately 22,000 shares for $14 million during the quarter.

buyback
40%
neutralMay 7

Ongoing share-based compensation and restricted stock issuance.

dilution risk
30%
bullishMay 7

Net earnings increased 26% year-over-year to $128.2 million.

earnings beat
80%
bullishMay 7

Operating margin increased 150 basis points to 17.5% due to favorable absorption.

margin expansion
70%
bullishMay 7

Repurchased approximately 22,000 shares for $14 million during the quarter.

buyback
40%
neutralMay 7

Ongoing share-based compensation and restricted stock issuance.

dilution risk
30%

Filing History

10-QMay 7, 2026
Expand Sequence

The Q1 2026 filing paints a picture of a company in a high-growth phase, successfully capturing the tailwinds of increased defense spending and nuclear energy demand. The operational metrics are undeniably strong, with double-digit growth in sales and a significant jump in earnings per share. The expansion of the backlog to $4.3 billion provides a critical safety net and a predictable revenue stream for the next three years. However, the disconnect between accounting earnings and cash flow remains the central point of tension for investors. The rise in working capital needs and the continued negative operating cash flow suggest that the cost of supporting this growth is substantial. The company is essentially borrowing from its balance sheet and utilizing credit facilities to fund the gap between production and collection. Ultimately, the investment thesis hinges on whether the current operational momentum can outpace the inherent risks of high debt and long-cycle government contracts. If Curtiss-Wright can stabilize its cash conversion cycle while maintaining its margin expansion, it remains a powerful compounder. Conversely, any disruption in the U.S. Navy's shipbuilding pipeline or a failure in the commercial nuclear prototype stage could rapidly erode the current valuation premium.

Disclaimer: The synthesis provided is generated by AI models and should not be construed as investment advice. Analysis is based solely on regulatory data present at the time of publication. Consult a financial advisor for specific investment strategies.